Hutchmed Drc Stock Market Value
| HCM Stock | USD 14.96 0.07 0.47% |
| Symbol | HUTCHMED |
Will Pharmaceuticals sector continue expanding? Could HUTCHMED diversify its offerings? Factors like these will boost the valuation of HUTCHMED DRC. Market participants price HUTCHMED higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every HUTCHMED DRC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 16.333 | Earnings Share 2.65 | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
Understanding HUTCHMED DRC requires distinguishing between market price and book value, where the latter reflects HUTCHMED's accounting equity. The concept of intrinsic value - what HUTCHMED DRC's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push HUTCHMED DRC's price substantially above or below its fundamental value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, HUTCHMED DRC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
HUTCHMED DRC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HUTCHMED DRC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HUTCHMED DRC.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in HUTCHMED DRC on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding HUTCHMED DRC or generate 0.0% return on investment in HUTCHMED DRC over 90 days. HUTCHMED DRC is related to or competes with Bausch Health, Perrigo Company, Ideaya Biosciences, Supernus Pharmaceuticals, Catalyst Pharmaceuticals, Scholar Rock, and Adaptive Biotechnologies. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immuno... More
HUTCHMED DRC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HUTCHMED DRC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HUTCHMED DRC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 9.55 | |||
| Value At Risk | (2.69) | |||
| Potential Upside | 2.84 |
HUTCHMED DRC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HUTCHMED DRC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HUTCHMED DRC's standard deviation. In reality, there are many statistical measures that can use HUTCHMED DRC historical prices to predict the future HUTCHMED DRC's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | 0.1711 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HUTCHMED DRC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
HUTCHMED DRC February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.1811 | |||
| Mean Deviation | 1.45 | |||
| Coefficient Of Variation | (4,425) | |||
| Standard Deviation | 1.9 | |||
| Variance | 3.61 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | 0.1711 | |||
| Maximum Drawdown | 9.55 | |||
| Value At Risk | (2.69) | |||
| Potential Upside | 2.84 | |||
| Skewness | 0.9077 | |||
| Kurtosis | 1.58 |
HUTCHMED DRC Backtested Returns
As of now, HUTCHMED Stock is very steady. HUTCHMED DRC holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of volatility over the last 3 months. We have found twenty-three technical indicators for HUTCHMED DRC, which you can use to evaluate the volatility of the firm. Please check out HUTCHMED DRC's risk adjusted performance of (0.01), and Market Risk Adjusted Performance of 0.1811 to validate if the risk estimate we provide is consistent with the expected return of 0.0049%. The company retains a Market Volatility (i.e., Beta) of -0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning HUTCHMED DRC are expected to decrease at a much lower rate. During the bear market, HUTCHMED DRC is likely to outperform the market. HUTCHMED DRC presently retains a risk of 1.93%. Please check out HUTCHMED DRC kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if HUTCHMED DRC will be following its current trending patterns.
Auto-correlation | -0.46 |
Modest reverse predictability
HUTCHMED DRC has modest reverse predictability. Overlapping area represents the amount of predictability between HUTCHMED DRC time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HUTCHMED DRC price movement. The serial correlation of -0.46 indicates that about 46.0% of current HUTCHMED DRC price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.58 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out HUTCHMED DRC Correlation, HUTCHMED DRC Volatility and HUTCHMED DRC Performance module to complement your research on HUTCHMED DRC. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
HUTCHMED DRC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.